Suraksha Diagnostic's Q1 FY 2026-27 Quarterly Results
- 13 Aug 2026
Result Summary
- Suraksha Diagnostic Ltd reported a 7.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 20.7%.
- Its expenses for the quarter were up by 0.1% QoQ and 16.7% YoY.
- The net profit increased 108.6% QoQ and increased 40.0% YoY.
- The earnings per share (EPS) of Suraksha Diagnostic Ltd stood at 2.5 during Q1 FY 2026-27.
Financial Statments for Q1 FY 2026-27
(₹ crores) | Q1FY27 | Q4FY26 | Q1FY26 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 88.73 | 82.20 | 73.49 | 7.9% | 20.7% |
Total Expenses | 72.26 | 72.22 | 61.91 | 0.1% | 16.7% |
Profit Before Tax | 16.53 | 9.98 | 12.47 | 65.6% | 32.6% |
Tax | 3.68 | 3.82 | 3.29 | -3.7% | 11.9% |
Profit After Tax | 12.85 | 6.16 | 9.18 | 108.6% | 40.0% |
Earnings Per Share | 2.50 | 1.21 | 1.80 | 106.6% | 38.9% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Suraksha Diagnostic Ltd is a company that operates within the healthcare industry, focusing on providing diagnostic services. Typically, companies in this sector offer a range of services including imaging, pathology, and other laboratory testing. As of the data available up to October 2023, specific recent major developments or changes in the company's offerings or strategic direction are not provided. Therefore, this report will concentrate on the financial performance as given in the quarterly data.
Revenue
In Q1FY27, Suraksha Diagnostic Ltd reported a Total Income of ₹88.73 crores, which indicates a growth of 7.9% from the previous quarter (Q4FY26) where the Total Income was ₹82.20 crores. This also represents a significant year-over-year increase of 20.7% compared to Q1FY26, when the Total Income stood at ₹73.49 crores. The upward trend in revenue suggests a robust quarterly and annual performance in terms of income generation.
Profitability
The Profit Before Tax (PBT) for Suraksha Diagnostic Ltd in Q1FY27 was ₹16.53 crores. This shows a substantial quarter-over-quarter increase of 65.6% from Q4FY26, where the PBT was ₹9.98 crores. Year-over-year, there was a 32.6% increase from Q1FY26's PBT of ₹12.47 crores. The Profit After Tax (PAT) in Q1FY27 amounted to ₹12.85 crores, which reflects a notable 108.6% rise quarter-over-quarter and a 40.0% increase year-over-year. Earnings Per Share (EPS) also saw a significant increase, reaching ₹2.50 in Q1FY27 from ₹1.21 in Q4FY26, marking a 106.6% growth, and from ₹1.80 in Q1FY26, indicating a 38.9% rise.
Operating Metrics
Total Expenses for Q1FY27 were ₹72.26 crores, showing a marginal increase of 0.1% from Q4FY26's expenses of ₹72.22 crores. Year-over-year, the Total Expenses rose by 16.7% from Q1FY26, where expenses were ₹61.91 crores. The tax expense in Q1FY27 was ₹3.68 crores, showing a slight decrease of 3.7% from the previous quarter, Q4FY26, which had a tax expense of ₹3.82 crores, and an increase of 11.9% from Q1FY26, which was ₹3.29 crores. This data illustrates the cost structure and tax implications for the company over the reported periods.
FAQs
Suraksha Diagnostic Ltd announced its Q1 FY 2026-27 results on 13 August, 2026.
Suraksha Diagnostic Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Suraksha Diagnostic Ltd Q1 FY 2026-27 results include:
- Revenue: ₹88.73 crore
- Net Profit: ₹12.85 crore
- EBITDA: ₹31.53 crore
- Year-over-Year Growth: 20.7%
- Quarter-over-Quarter Growth: 7.9%
Suraksha Diagnostic Ltd reported a net profit of ₹12.85 crore in Q1 FY 2026-27, reflecting a 40.0% year-over-year growth.
Suraksha Diagnostic Ltd posted a revenue of ₹88.73 crore in Q1 FY 2026-27.